AC Immune Ltd Stock
Price
Target price
€3.07
€3.07
1.380%
0.04
1.380%
€14.55
21.05.24 / Tradegate
WKN: A2AR5F / Symbol: ACIU / Name: AC Immune / Stock / Biotechnology & Medical Research / Micro Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
AC Immune Ltd Stock
There is an upward development for AC Immune Ltd compared to yesterday, with an increase of €0.040 (1.380%).
Currently there is a rather positive sentiment for AC Immune Ltd with 3 Buy predictions and 0 Sell predictions.
Based on the current price of 3.07 € the target price of 14 € shows a potential of 356.03% for AC Immune Ltd which would more than double the current price.
For the coming years our community has positive and negative things to say abot the AC Immune Ltd stock. Criterium "Worthwhile Investment for the next years" gathered the most positive votes but regarding "Innovation" there were negative voices in the community.
Pros and Cons of AC Immune Ltd in the next few years
Pros
?
M***** P*******
?
C******** o* t** e**********
?
S********** s********
Cons
?
W********* I********* f** t** n*** y****
?
B****
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Comments
AC Immune SA (NASDAQ: ACIU) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $16.00 price target on the stock.
Show more
Ratings data for ACIU provided by MarketBeat
AC Immune SA (NASDAQ: ACIU) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $16.00 price target on the stock.
Show more
Ratings data for ACIU provided by MarketBeat
AC Immune SA (NASDAQ: ACIU) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $16.00 price target on the stock.
Show more
Ratings data for ACIU provided by MarketBeat